Evidence map›Paper›PMID 39548855›Full record

ArticleJournal of investigative medicine high impact case reports

Primary Thyroid Lymphoma: A Rare Diagnosis Treated With Polatuzumab Vedotin.

Rupam Sharma, Arin Orogian, Ralph Garcia-Pacheco, Tung Trang, Matthew Clarke, William Stull, Stanley Kim

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rupam SharmaDepartment of Medicine, Kern Medical, Bakersfield, CA, USA.ORCID 0000-0003-3457-4371
Arin OrogianDepartment of Medicine, Kern Medical, Bakersfield, CA, USA.
Ralph Garcia-PachecoDepartment of Medicine, Kern Medical, Bakersfield, CA, USA.
Tung TrangDepartment of Medicine, Kern Medical, Bakersfield, CA, USA.
Matthew ClarkeDepartment of Medicine, Kern Medical, Bakersfield, CA, USA.
William StullDepartment of Medicine, Kern Medical, Bakersfield, CA, USA.
Stanley KimDepartment of Medicine, Kern Medical, Bakersfield, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary thyroid lymphoma is one of the rare and distinct type of extra nodal lymphomas originating within the thyroid gland. It accounts for less than 5% of all thyroid malignancies and 2% of extra nodal lymphomas. It predominantly affects older adults, with a higher incidence in women. Patients typically present with a rapidly enlarging thyroid mass, accompanied by clinical symptoms of compression such as dysphagia, dyspnea, and hoarseness. Diagnosis is established through a combination of fine-needle aspiration, core needle biopsy, and advanced imaging techniques. Standard treatment involves a multimodal strategy of chemotherapy, often with the addition of radiotherapy and surgical intervention. Herein presented is the first reported case of diffuse large B-cell lymphoma treated with Pola-R-CHP.

Indexed as

Lymphoma, Large B-Cell, DiffuseThyroid NeoplasmsAgedAntibodies, MonoclonalAntineoplastic Agents, ImmunologicalAntineoplastic Combined Chemotherapy ProtocolsBiopsy, Fine-NeedleFemaleHumansImmunoconjugatesMiddle AgedAntibodies, MonoclonalAntineoplastic Agents, ImmunologicalImmunoconjugatespolatuzumab vedotinchemotherapy for primary thyroid lymphomaPola-R-CHPprimary diffuse large B-cell lymphoma

Identifiers

PMID39548855
PMCPMC11569482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.